Assignee
INVOX PHARMA LTD
GB·4 granted patents·6 pending applications·1 citations·filing 2019–2025
Top patents by PatentIndex Score
10 records- 0177US2025346626A1Compounds, compositions, and methods for the treatment of diseaseINVOX PHARMA LTD·Filed 2024·Application pending·0 cites
- 0269US12297283B2Fc binding fragments comprising an OX40 antigen-binding siteINVOX PHARMA LTD·Filed 2019·Granted May 13, 2025·1 cites·15 claims
- 0368US2025368730A1Anti-mesothelin antibodiesINVOX PHARMA LTD·Filed 2025·Application pending·0 cites
- 0466US2025084176A1Fc binding fragments comprising a cd137 antigen-binding siteINVOX PHARMA LTD·Filed 2024·Application pending·0 cites
- 0558US2025346679A1Antibody molecules that bind pd-l1 and cd137INVOX PHARMA LTD·Filed 2025·Application pending·0 cites
- 0657US12325742B2Anti-mesothelin antibodiesINVOX PHARMA LTD·Filed 2019·Granted Jun 10, 2025·0 cites·20 claims
- 0757US2025361312A1Fc binding fragments comprising an ox40 antigen-binding siteINVOX PHARMA LTD·Filed 2025·Application pending·0 cites
- 0852US12344672B2Antibody molecules that bind PD-L1 and CD137INVOX PHARMA LTD·Filed 2019·Granted Jul 1, 2025·0 cites·25 claims
- 0950US2025270324A1Antibody moleculesINVOX PHARMA LTD·Filed 2025·Application pending·0 cites
- 1038US12534534B2Anti-CD137 antibodiesINVOX PHARMA LTD·Filed 2019·Granted Jan 27, 2026·0 cites·21 claims
Join the waitlist — get patent alerts
Get an alert when INVOX PHARMA LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →